Literature DB >> 7115333

Toxic effects of human eosinophil products on isolated rat heart cells in vitro.

P C Tai, D J Hayes, J B Clark, C J Spry.   

Abstract

Rat heart cells and mitochondria were incubated with supernatants from eosinophils or neutrophils that had been stimulated with zymosan-C3b. Supernatants from eosinophils, but not neutrophils, were toxic to rat heart cells in a dose-dependent manner. This was associated with an increased O2 uptake, which was blocked by either 1 mM-cyanide or 100 microM-ouabain. Supernatants from eosinophils, but not neutrophils, caused a decrease in O2 uptake by rat heart mitochondria utilizing pyruvate (+ malate) but not other substrates. The activity of pyruvate dehydrogenase (EC 1.2.4.1) from rat heart was inhibited by Ca2+-free eosinophil supernatants. The activity of oxoglutarate dehydrogenase (EC 1.2.4.2) was also inhibited but not that of lipoamide dehydrogenase (EC 1.6.4.3). Prior incubation with heparin prevented these effects of eosinophil supernatants on heart cells, suggesting that they were caused by eosinophil cationic proteins. Other cationic proteins, including poly-L-lysine and poly-L-arginine were also toxic to rat heart cells, but these reduced O2 uptake. It was concluded that granulocyte secretion products containing eosinophil cationic proteins are toxic to isolated rat heart cells in vitro. This may be due to an initial increase in membrane permeability, which may lead to activation of (Na+ + K+)-dependent ATPase and increased O2 uptake. A second step may involve inhibition of pyruvate dehydrogenase by the same products, leading to a decreased O2 uptake. It is suggested that these mechanisms could contribute to the development of cardiac injury and myocardial disease in clinical situations where many degranulated eosinophils are present.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7115333      PMCID: PMC1158317          DOI: 10.1042/bj2040075

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  The respiratory chain and oxidative phosphorylation.

Authors:  B CHANCE; G R WILLIAMS
Journal:  Adv Enzymol Relat Subj Biochem       Date:  1956

2.  Studies on blood eosinophils. II. Patients with Löffler's cardiomyopathy.

Authors:  C J Spry; P C Tai
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

Review 3.  The eosinophil and its role in immunity to helminth infection.

Authors:  A E Butterworth
Journal:  Curr Top Microbiol Immunol       Date:  1977       Impact factor: 4.291

4.  The heart in eosinophilic leukaemia.

Authors:  I F Brockington; L Luzzatto; B O Osunkoya
Journal:  Afr J Med Sci       Date:  1970-07

5.  Human eosinophils: surface receptors and antibody-dependent cytotoxicity.

Authors:  D E Van Epps; A D Bankhurst
Journal:  J Lab Clin Med       Date:  1978-04

Review 6.  The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.

Authors:  M J Chusid; D C Dale; B C West; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1975-01       Impact factor: 1.889

7.  Lipoamide dehydrogenase regulation in rat brain.

Authors:  T T Ngo; A Barbeau
Journal:  Can J Neurol Sci       Date:  1978-02       Impact factor: 2.104

8.  Human eosinophils. Purification and cytotoxic capability of eosinophils from patients with the hypereosinophilic syndrome.

Authors:  J E Parrillo; A S Fauci
Journal:  Blood       Date:  1978-03       Impact factor: 22.113

9.  Radioimmunoassay of human eosinophil cationic protein.

Authors:  P Venge; L E Roxin; I Olsson
Journal:  Br J Haematol       Date:  1977-11       Impact factor: 6.998

10.  Complement-mediated killing of schistosomula of Schistosoma mansoni by rat eosinophils in vitro.

Authors:  F J Ramalho-Pinto; D J McLaren; S R Smithers
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

View more
  44 in total

1.  Improvement of eosinophilic heart disease after steroid therapy: successful demonstration by endomyocardial biopsied specimens.

Authors:  S Hayashi; M Isobe; Y Okubo; J Suzuki; Y Yazaki; M Sekiguchi
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

Review 2.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

3.  Progressive dilated cardiomyopathy in a patient with longstanding and complete prednisone-induced hematological remission of idiopathic hypereosinophilic syndrome.

Authors:  R Christen; R Morant; J Schneider; R Jenni; J Fehr
Journal:  Klin Wochenschr       Date:  1989-03-15

4.  Eosinophilic esophagitis: interactions with gastroesophageal reflux disease.

Authors:  Edaire Cheng; Rhonda F Souza; Stuart Jon Spechler
Journal:  Gastroenterol Clin North Am       Date:  2014-03-24       Impact factor: 3.806

5.  Acute necrotising eosinophilic myocarditis.

Authors:  C A Herzog; D C Snover; N A Staley
Journal:  Br Heart J       Date:  1984-09

Review 6.  Functional role of eosinophils in gastrointestinal inflammation.

Authors:  Simon P Hogan
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

7.  Effects of monoclonal antibodies to adhesion molecules on eosinophilic myocarditis in Toxocara canis-infected CBA/J mice.

Authors:  S Hokibara; M Takamoto; M Isobe; K Sugane
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

8.  Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart.

Authors:  Nicola L Diny; Xuezhou Hou; Jobert G Barin; Guobao Chen; Monica V Talor; Julie Schaub; Stuart D Russell; Karin Klingel; Noel R Rose; Daniela Čiháková
Journal:  Eur J Immunol       Date:  2016-10-25       Impact factor: 5.532

9.  The idiopathic hypereosinophilic syndrome.

Authors:  M A Alfaham; S D Ferguson; B Sihra; J Davies
Journal:  Arch Dis Child       Date:  1987-06       Impact factor: 3.791

10.  Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome.

Authors:  P C Tai; M E Holt; P Denny; A R Gibbs; B D Williams; C J Spry
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.